These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28556355)

  • 21. Evaluating the performance of Bayesian and restricted maximum likelihood estimation for stepped wedge cluster randomized trials with a small number of clusters.
    Grantham KL; Kasza J; Heritier S; Carlin JB; Forbes AB
    BMC Med Res Methodol; 2022 Apr; 22(1):112. PubMed ID: 35418034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical efficiency and optimal design for stepped cluster studies under linear mixed effects models.
    Girling AJ; Hemming K
    Stat Med; 2016 Jun; 35(13):2149-66. PubMed ID: 26748662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of permutation tests for the analysis of parallel and stepped-wedge cluster-randomized trials.
    Wang R; De Gruttola V
    Stat Med; 2017 Aug; 36(18):2831-2843. PubMed ID: 28464567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.
    Cunanan KM; Carlin BP; Peterson KA
    Clin Trials; 2016 Dec; 13(6):641-650. PubMed ID: 27430710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Information growth for sequential monitoring of clinical trials with a stepped wedge cluster randomized design and unknown intracluster correlation.
    Brown SP; Shoben AB
    Clin Trials; 2020 Apr; 17(2):176-183. PubMed ID: 32026713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of cluster randomised stepped wedge trials with repeated cross-sectional samples.
    Hemming K; Taljaard M; Forbes A
    Trials; 2017 Mar; 18(1):101. PubMed ID: 28259174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.
    Kristunas CA; Smith KL; Gray LJ
    Trials; 2017 Mar; 18(1):109. PubMed ID: 28270224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key concepts in clinical epidemiology: Stepped wedge trials.
    Hooper R
    J Clin Epidemiol; 2021 Sep; 137():159-162. PubMed ID: 33892089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed effects approach to the analysis of the stepped wedge cluster randomised trial-Investigating the confounding effect of time through simulation.
    Nickless A; Voysey M; Geddes J; Yu LM; Fanshawe TR
    PLoS One; 2018; 13(12):e0208876. PubMed ID: 30543671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inclusion of unexposed clusters improves the precision of fixed effects analysis of stepped-wedge cluster randomized trials.
    Lee KM; Ma X; Yang GM; Cheung YB
    Stat Med; 2022 Jul; 41(15):2923-2938. PubMed ID: 35352382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Missing binary outcomes under covariate-dependent missingness in cluster randomised trials.
    Hossain A; DiazOrdaz K; Bartlett JW
    Stat Med; 2017 Aug; 36(19):3092-3109. PubMed ID: 28557022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accounting for confounding by time, early intervention adoption, and time-varying effect modification in the design and analysis of stepped-wedge designs: application to a proposed study design to reduce opioid-related mortality.
    Rennert L; Heo M; Litwin AH; Gruttola V
    BMC Med Res Methodol; 2021 Mar; 21(1):53. PubMed ID: 33726711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size determinations for stepped-wedge clinical trials from a three-level data hierarchy perspective.
    Heo M; Kim N; Rinke ML; Wylie-Rosett J
    Stat Methods Med Res; 2018 Feb; 27(2):480-489. PubMed ID: 26988927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Admissible multiarm stepped-wedge cluster randomized trial designs.
    Grayling MJ; Mander AP; Wason JMS
    Stat Med; 2019 Mar; 38(7):1103-1119. PubMed ID: 30402914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Information content of cluster-period cells in stepped wedge trials.
    Kasza J; Forbes AB
    Biometrics; 2019 Mar; 75(1):144-152. PubMed ID: 30051909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review showed that stepped-wedge cluster randomized trials often did not reach their planned sample size.
    Eichner FA; Groenwold RHH; Grobbee DE; Oude Rengerink K
    J Clin Epidemiol; 2019 Mar; 107():89-100. PubMed ID: 30458261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches.
    Copas AJ; Lewis JJ; Thompson JA; Davey C; Baio G; Hargreaves JR
    Trials; 2015 Aug; 16():352. PubMed ID: 26279154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sample size determination for GEE analyses of stepped wedge cluster randomized trials.
    Li F; Turner EL; Preisser JS
    Biometrics; 2018 Dec; 74(4):1450-1458. PubMed ID: 29921006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Random effect misspecification in stepped wedge designs.
    Voldal EC; Xia F; Kenny A; Heagerty PJ; Hughes JP
    Clin Trials; 2022 Aug; 19(4):380-383. PubMed ID: 35257614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.